Biotech Distilled
Substack ↗ Subscribe
Subscribe Substack ↗ About

Home › Modalities › Protein

Protein (88 companies)

Ticker Company Therapeutic areas Programs Lead stage Programs
ABSI Absci DermatologyGI/Hepatology+1 6 Phase 1 6
ACIU AC Immune Neurology Rare 4 Phase 3 10
ACRS Aclaris Therapeutics DermatologyGI/Hepatology+1 Rare 4 Phase 2 8
ABOS Acumen Pharmaceuticals Neurology 4 Phase 2 4
ADAG Adagene Oncology 10 Phase 2 10
ADCT ADC Therapeutics Oncology 5 Approved 5
ADMA Adma Biologics ImmunologyInfectious Disease Rare 4 Approved 4
AGMB Agomab Therapeutics ImmunologyRespiratory Rare 2 Phase 2 4
AKBA Akebia Therapeutics HematologyOphthalmology+2 Rare 3 Approved 10
ANAB AnaptysBio DermatologyGI/Hepatology+2 Rare 6 Approved 6
ANIX Anixa Biosciences Oncology 2 Phase 1 3
ANNX Annexon HematologyNeurology+2 Rare 5 Phase 3 6
APGE Apogee Therapeutics DermatologyGI/Hepatology+1 Rare 9 Phase 2 9
APVO Aptevo Therapeutics Oncology 8 Phase 1 8
RCUS Arcus Biosciences DermatologyImmunology+1 2 Phase 3 6
BEAM Beam Therapeutics HematologyMetabolic+1 Rare 1 Phase 2 6
BCAX Bicara Therapeutics Oncology 4 Phase 2 4
BCRX Biocryst Pharmaceuticals DermatologyImmunology+1 Rare 2 Approved 4
BCTX BriaCell Therapeutics Oncology 1 Phase 3 7
CAPR Capricor Therapeutics Infectious DiseaseNeurology Rare 1 NDA Submitted 2
CLDX Celldex Therapeutics DermatologyImmunology+1 7 Phase 3 7
CMMB Chemomab Therapeutics GI/HepatologyImmunology+1 Rare 4 Phase 2 4
CLYM Climb Bio HematologyImmunology+1 Rare 6 Phase 2 7
CHRS Coherus Oncology Oncology 3 Approved 3
CMPX Compass Therapeutics Oncology 15 Phase 2 15
CGEN Compugen Oncology 7 Phase 3 7
CNTB Connect Biopharma Respiratory 4 Phase 2 4
CRVS Corvus Pharmaceuticals DermatologyOncology 1 Phase 3 4
CBIO Crescent Biopharma Oncology 10 Phase 2 10
CUE Cue Biopharma ImmunologyOncology 6 Phase 2 6
CGEM Cullinan Therapeutics HematologyImmunology+2 Rare 9 NDA Submitted 10
CYDY CytoDyn NeurologyOncology 3 Phase 2 3
CTMX CytomX Therapeutics Oncology 6 Phase 1 6
DBVT DBV Technologies Immunology 2 NDA Submitted 2
DYN Dyne Therapeutics MetabolicNeurology Rare 1 NDA Submitted 10
ELDN Eledon Pharmaceuticals ImmunologyMetabolic+1 Rare 3 Phase 2 3
ERAS Erasca Oncology 1 Phase 1 3
ETON Eton Pharmaceuticals GI/HepatologyInfectious Disease+2 Rare 1 Approved 14
EVMN Evommune DermatologyImmunology+1 3 Phase 2 5
EXEL Exelixis CardiovascularOncology 5 Approved 22
FBRX Forte Biosciences DermatologyGI/Hepatology 3 Phase 2 3
FBIO Fortress Biotech DermatologyHematology+2 Rare 3 Approved 12
IDYA IDEAYA Biosciences Oncology 3 NDA Submitted 13
IMTX Immatics Oncology 6 Phase 3 8
IBRX ImmunityBio Infectious DiseaseOncology 6 Approved 16
IMCR Immunocore DermatologyInfectious Disease+2 11 Approved 11
IMNM Immunome Oncology Rare 7 NDA Submitted 9
IMVT Immunovant ImmunologyNeurology Rare 6 Phase 3 6
INAB IN8bio ImmunologyOncology 1 Phase 2 6
INBX Inhibrx Biosciences Oncology 6 NDA Submitted 6
INSM Insmed CardiovascularImmunology+2 Rare 4 Approved 17
JBIO Jade Biosciences ImmunologyRenal Rare 4 Phase 2 4
JANX Janux Therapeutics Oncology 2 Phase 1 3
KAPA Kairos Pharma Oncology 4 Phase 2 13
KOD Kodiak Sciences Ophthalmology 8 Phase 3 8
LRMR Larimar Therapeutics Neurology Rare 1 NDA Submitted 1
MDNAF Medicenna Therapeutics Oncology 9 Phase 2 9
MLTX MoonLake Immunotherapeutics DermatologyImmunology Rare 4 Phase 3 4
NKTR Nektar Therapeutics DermatologyImmunology+2 11 Phase 3 11
NBP NovaBridge Biosciences OncologyOphthalmology 6 Phase 2 6
OCGN Ocugen Infectious DiseaseOphthalmology Rare 3 Phase 3 12
OCS Oculis Holding NeurologyOphthalmology Rare 1 Phase 3 4
OMER Omeros HematologyNeurology+2 Rare 4 Approved 6
ORKA Oruka Therapeutics DermatologyImmunology Rare 6 Phase 2 7
OTLK Outlook Therapeutics Ophthalmology 3 Approved 3
PMN ProMIS Neurosciences Neurology Rare 6 Phase 1 6
QTTB Q32 Bio Dermatology 2 Phase 2 2
SABS SAB Biotherapeutics Metabolic 1 Phase 2 1
SPRB Spruce Biosciences Metabolic Rare 2 Preclinical 2
SYRE Spyre Therapeutics DermatologyImmunology Rare 12 Phase 2 12
SMMT Summit Therapeutics Oncology 5 NDA Submitted 5
STRO Sutro Biopharma Oncology 4 Phase 1 4
SNDX Syndax Pharmaceuticals ImmunologyOncology+1 Rare 2 Approved 8
TECX Tectonic Therapeutic Cardiovascular Rare 3 Phase 2 3
TGTX Tg Therapeutics Neurology Rare 5 Approved 6
TVTX Travere Therapeutics MetabolicRenal Rare 1 Approved 7
RARE Ultragenyx Pharmaceutical CardiovascularGI/Hepatology+2 Rare 5 Approved 12
VNDA Vanda Pharmaceuticals CardiovascularDermatology+6 Rare 1 Approved 27
PCVX Vaxcyte Infectious Disease 6 Phase 3 6
VERA Vera Therapeutics Infectious DiseaseRenal Rare 6 Approved 6
VIR Vir Biotechnology Infectious DiseaseOncology Rare 10 Phase 3 10
VRDN Viridian Therapeutics ImmunologyOphthalmology 5 Approved 5
VOR Vor Biopharma ImmunologyNeurology Rare 2 Phase 3 2
VYGR Voyager Therapeutics MetabolicNeurology Rare 1 Phase 1 9
XNCR Xencor HematologyImmunology+4 Rare 36 Approved 36
ZBIO Zenas BioPharma DermatologyImmunology+2 Rare 7 NDA Submitted 11
ZURA Zura Bio DermatologyImmunology Rare 5 Phase 2 5
ZYME Zymeworks OncologyRespiratory 11 Approved 11